[Federal Register Volume 61, Number 94 (Tuesday, May 14, 1996)]
[Notices]
[Pages 24331-24332]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-12006]



-----------------------------------------------------------------------


DEPARTMENT OF JUSTICE

Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--International Pharmaceutical Aerosol Consortium 
for Toxicology Testing of HFA-227 (IPACT-II) Supplemental Filing

    Notice is hereby given that, on April 15, 1995, pursuant to section 
6(a) of the National Cooperative Research and Production Act of 1993, 
15 U.S.C. 4301 et seq. (``the Act''), the International Pharmaceutical 
Aerosol Consortium for Toxicology Testing of HFA-227 (``IPACT-II'') has 
filed written

[[Page 24332]]

notifications simultaneously with the Attorney General and the Federal 
Trade Commission disclosing the addition of a new member. The 
notifications were filed for the purpose of extending the Act's 
provisions limiting the recovery of antitrust plaintiffs to actual 
damages under specified circumstances. Specifically, Astra AB, 
Sodertalje, Sweden, became a member of IPACT-II on February 2, 1996.
    No other changes have been made in either the membership or planned 
activities of IPACT-II. Membership in this group research project 
remains open, and IPACT-II intends to file additional written 
notification disclosing all changes in membership.
    On February 21, 1991, IPACT-II filed its original notification 
pursuant to section 6(a) of the Act. The Department of Justice 
published a notice in the Federal Register pursuant to section 6(b) of 
the Act on April 2, 1991 (56 FR 13489).
    The last notification was filed with the Department on May 25, 
1995. A notice has been published in the Federal Register on April 29, 
1996 (61 FR 18755).
Constance K. Robinson,
Director of Operations, Antitrust Division.
[FR Doc. 96-12006 Filed 5-13-96; 8:45 am]
BILLING CODE 4410-01-M